Insider Trading & Ownership - Edwards Martin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Edwards Martin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-20
Purchase
2023-11-22
5:09 pm
Verona Pharma plcVRNAEdwards Martin
Director
33,736$1.837$61,973144,800
(Direct)
View
2023-11-13
Purchase
2023-11-15
7:00 pm
Morphic Holding Inc.MORFEdwards Martin
Director
2,376$20.54$48,8032,376
(Direct)
View
2021-05-04
Sale
2021-05-05
5:04 pm
Verona Pharma plcVRNAEdwards Martin
Director
12,024$0.8397$10,097111,064
(Direct)
View
2021-02-01
Sale
2021-02-03
7:09 pm
Verona Pharma plcVRNAEdwards Martin
Director
13,688$0.9938$13,603123,088
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-16
Disposition
2024-08-21
4:36 pm
N/A
2030-12-01
Morphic Holding Inc.MORFEdwards Martin
Director
89,625$00
(Direct)
View
2024-06-18
Option Award
2024-06-20
4:07 pm
N/A
2034-06-17
Inozyme Pharma Inc.INZYEdwards Martin
Director
28,000$028,000
(Direct)
View
2024-06-04
Option Award
2024-06-05
8:21 pm
N/A
2034-06-03
Morphic Holding Inc.MORFEdwards Martin
Director
23,168$023,168
(Direct)
View
2024-04-29
Option Award
2024-04-30
4:17 pm
N/A
2034-04-28
Verona Pharma plcVRNAEdwards Martin
Director
240,000$0240,000
(Direct)
View
2023-09-26
Disposition
2023-09-26
4:30 pm
N/A
2030-08-03
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
35,961$00
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:05 pm
N/A
2033-06-12
Inozyme Pharma Inc.INZYEdwards Martin
Director
16,000$016,000
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:13 pm
N/A
2033-06-07
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
2,137$08,422
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:13 pm
N/A
N/A
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
1,815$93.618,422
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:13 pm
N/A
2033-06-07
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
169$73.688,422
(Direct)
View
2023-06-01
Option Award
2023-06-05
6:59 pm
N/A
2033-05-31
Morphic Holding Inc.MORFEdwards Martin
Director
12,535$012,535
(Direct)
View
2023-04-28
Option Award
2023-04-28
4:22 pm
N/A
2033-04-27
Verona Pharma plcVRNAEdwards Martin
Director
96,000$096,000
(Direct)
View
2022-06-10
Option Award
2022-06-14
07:48 am
N/A
2032-06-09
Inozyme Pharma Inc.INZYEdwards Martin
Director
9,367$09,367
(Direct)
View
2022-06-08
Option Award
2022-06-10
7:00 pm
N/A
2032-06-07
Morphic Holding Inc.MORFEdwards Martin
Director
17,550$017,550
(Direct)
View
2022-06-08
Option Award
2022-06-09
4:20 pm
N/A
2032-06-08
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
5,620$010,441
(Direct)
View
2022-06-08
Option Award
2022-06-09
4:20 pm
N/A
N/A
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
4,242$34.7610,441
(Direct)
View
2022-06-08
Option Award
2022-06-09
4:20 pm
N/A
2032-06-08
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
520$24.0210,441
(Direct)
View
2022-04-28
Option Award
2022-04-29
4:44 pm
N/A
2032-04-27
Verona Pharma plcVRNAEdwards Martin
Director
200,000$0200,000
(Direct)
View
2021-06-16
Option Award(A)
2022-04-29
4:10 pm
N/A
2031-06-16
Morphic Holding Inc.MORFEdwards Martin
Director
9,996$09,996
(Direct)
View
2022-01-03
Option Award
2022-01-05
4:02 pm
N/A
N/A
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
59$27.32158
(Direct)
View
2022-01-03
Option Award
2022-01-05
4:02 pm
N/A
2032-01-03
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
99$16.14158
(Direct)
View
2021-09-30
Option Award
2021-10-04
4:53 pm
N/A
2031-09-29
KalVista Pharmaceuticals Inc.KALVEdwards Martin
Director
10,000$010,000
(Direct)
View
2021-08-09
Option Award
2021-08-10
4:46 pm
N/A
2031-08-08
Verona Pharma plcVRNAEdwards Martin
Director
64,000$064,000
(Direct)
View
2021-06-23
Option Award
2021-06-24
4:17 pm
N/A
2031-06-22
Inozyme Pharma Inc.INZYEdwards Martin
Director
9,367$09,367
(Direct)
View
2021-06-16
Option Award
2021-06-17
7:07 pm
N/A
2031-06-16
Morphic Holding Inc.MORFEdwards Martin
Director
12,000$012,000
(Direct)
View
2021-06-10
Option Award
2021-06-14
4:11 pm
N/A
2031-06-10
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
5,000$05,000
(Direct)
View

Ownership
2021-01-04
8:37 pm
N/A
N/A
Verona Pharma plcRNAEdwards Martin
Director
0$0136,776
(Direct)
View
2020-12-01
Option Award
2020-12-03
9:49 pm
N/A
2030-12-01
Morphic Holding Inc.MORFEdwards Martin
Director
24,000$024,000
(Direct)
View

Ownership
2020-12-03
9:47 pm
N/A
N/A
Morphic Holding Inc.MORFEdwards Martin
Director
0$00
(Direct)
View
2020-10-01
Option Award
2020-10-02
8:39 pm
N/A
2030-09-30
KalVista Pharmaceuticals Inc.KALVEdwards Martin
Director
7,000$07,000
(Direct)
View
2020-08-03
Option Award
2020-08-04
4:41 pm
N/A
2030-08-03
REATA PHARMACEUTICALS INCRETAEdwards Martin
Director
16,300$016,300
(Direct)
View
2020-07-23
Option Award
2020-07-24
4:49 pm
N/A
2030-07-22
Inozyme Pharma Inc.INZYEdwards Martin
Director
9,367$09,367
(Direct)
View
(A) Indicate amendment filing.